Baxter Healthcare and Micrel Medical Devices announce distribution agreement in Australia and New Zealand to support Parenteral Nutrition patients

Press Release
  • Distribution agreement to supply Micrel Mini Rythmic PN+

PDF

Sydney, Australia -

Baxter Healthcare (Baxter), a global leader in clinical nutrition, and Micrel Medical, a medical device company specializing in infusion therapy, today announced an agreement for the distribution of the Micrel Mini Rythmic PN+ infusion pump for Parenteral Nutrition (PN).


Micrel Mini Rythmic PN+ is an ambulatory infusion pump supporting patients with Hospital-in-the-Home Parenteral Nutrition. As part of the agreement, Baxter Healthcare will be the sole distributor of the Micrel Mini Rythmic PN+ infusion pump and its accessories across ANZ.


PN therapy is the intravenous administration of nutrients. More than 300 patients across Australia and New Zealand receive Parenteral Nutrition at home.


Steven Flynn, Baxter Healthcare General Manager for Australia and New Zealand, said the partnership with Micrel Medical Devices would support patients in Australia and New Zealand with Hospital-in-the-Home Parenteral Nutrition.


“With a national network of pharmaceutical Compounding facilities in Australia and New Zealand, Baxter Healthcare is proud to support clinicians and their patients with diverse, patient-specific Parenteral Nutrition medicines and services,” Mr Flynn said.


“Throughout the COVID-19 pandemic, Baxter has continued to maintain secure supply and safe home-based services for Parenteral Nutrition patients in Australia and New Zealand. At the heart of Our Mission to Save and Sustain Lives is a commitment to innovation, quality and patient safety.”
Nikitas Machlis, Micrel Medical Devices Co-founder, CEO and Chair, said: “Micrel Medical Devices are pleased and excited by the appointment of Baxter as our new distributor partner for our PN pump in Australia and New Zealand.”
“Micrel is proud to deliver technology to support healthcare professionals around the world to improve patient care in the hospital or in the home. Baxter’s experience and coverage in Australia and New Zealand makes them the perfect partner for Micrel enabling more patients to access our range of infusion devices.”

 

About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxterhealthcare.com.au and follow us on LinkedIn.


About Micrel Medical Devices
For more than 40 years our medical technology company has been focused on designing and manufacturing drug delivery systems for use in both the hospital and home where portability provides improved patient freedom. We offer a full range of ambulatory volumetric and syringe infusion pumps, administration sets, carrying solutions and accessories. This is supported by an optional remote infusion monitoring platform designed for a broad array of infusion therapies. To learn more, visit www.micrelmed.com and follow us on LinkedIn.